CELSR2 and nonpapillary renal cell carcinoma: CELSR2, which encodes a family member of the cadherin EGF LAG seven-pass G-type receptors, has been identified in 1.8% of ccRCC patients in the KIRC database, which is not statistically different from the frequency in our cohort (4.00% in the VP group).